These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38236530)

  • 1. Retracted: si-PDGFR
    Longevity OMAC
    Oxid Med Cell Longev; 2024; 2024():9839740. PubMed ID: 38236530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. si-PDGFR
    Li Y; Yu H; Ma Q; Wei M; Liu X; Qi Y; Li C; Dong L; Zhang H
    Oxid Med Cell Longev; 2022; 2022():5081439. PubMed ID: 36275907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: A Molecular Mechanism Study to Reveal Hirudin's Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFR
    International BR
    Biomed Res Int; 2023; 2023():9809487. PubMed ID: 38188746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
    Markers D
    Dis Markers; 2023; 2023():9849123. PubMed ID: 37593569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Antitumor and apoptotic effects of 5-methoxypsoralen in U87MG human glioma cells and its effect on cell cycle, autophagy and PI3K/Akt signaling pathway.
    Guo H; He Y; Bu C; Peng Z
    Arch Med Sci; 2023; 19(2):556. PubMed ID: 37034538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 mitigates the cardioprotective effects of mesenchymal stem cell-secreted exosomes against infarction via HMGA2-mediated PI3K/AKT signaling.
    Jiao W; Hao J; Xie Y; Meng M; Gao W
    BMC Cardiovasc Disord; 2022 Mar; 22(1):95. PubMed ID: 35264108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway.
    Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
    Exp Ther Med; 2024 Jul; 28(1):280. PubMed ID: 38800047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9819824. PubMed ID: 37388518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling.
    Si F; Sun J; Wang C
    Exp Ther Med; 2021 Oct; 22(4):1090. PubMed ID: 34504544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Activation of PTEN/P13K/AKT Signaling Pathway by miRNA-124-3p-Loaded Nanoparticles to Regulate Oxidative Stress Attenuates Cardiomyocyte Regulation and Myocardial Injury.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9768785. PubMed ID: 38189020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: MiR-483 Promotes Colorectal Cancer Cell Biological Progression by Directly Targeting NDRG2 through Regulation of the PI3K/AKT Signaling Pathway and Epithelial-to-Mesenchymal Transition.
    Engineering JOH
    J Healthc Eng; 2022; 2022():9864791. PubMed ID: 36619243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Inhibiting Autophagy Pathway of PI3K/AKT/mTOR Promotes Apoptosis in SK-N-SH Cell Model of Alzheimer's Disease.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9780432. PubMed ID: 36714419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9756735. PubMed ID: 37502574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Leukemia Inhibitory Factor Facilitates Self-Renewal and Differentiation and Attenuates Oxidative Stress of BMSCs by Activating PI3K/AKT Signaling.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9819142. PubMed ID: 37388512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] Long non‑coding RNA RNCR3 promotes glioma progression involving the Akt/GSK‑3β pathway.
    Zhu B; Zhang S; Meng N; Zhang H; Yuan S; Zhang J
    Oncol Lett; 2023 Nov; 26(5):468. PubMed ID: 37780546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: TJZYF Improves Endometrial Receptivity through Regulating VEGF and PI3K/AKT Signaling Pathway.
    International BR
    Biomed Res Int; 2023; 2023():9846512. PubMed ID: 38188825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway.
    Markers D
    Dis Markers; 2023; 2023():9810565. PubMed ID: 37502573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retracted] Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer.
    Liu T; Liang X; Sun Y; Yang S
    Exp Ther Med; 2024 Jan; 27(1):1. PubMed ID: 38125358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of miR‑29a‑3p in exosomes on glioma cells by regulating the PI3K/AKT/HIF‑1α pathway.
    Liu Z; Yang Z; He L
    Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.